Dr. Laure Aurelian is a Professor of Pharmacology and Microbiology and Immunology at University of Maryland School of Medicine. Dr. Laure Aurelian completed her M. Sc. from Tel-Aviv University, Israel and PhD. from Johns Hopkins University, USA. Dr. Laure Aurelian’s laboratory studies signaling pathways involved in cell proliferation and apoptosis and has pioneered the application of antisense chemotherapy to the control of virus infections. Current studies focus on the use of a HSV-2 gene with serine-threonine protein kinase function (ICP10 PK) that activates the ERK signaling pathway in gene therapy of neurological disorders that involve apoptosis. Dr. Laure Aurelian along with her research team utilize a wide spectrum of molecular and cellular biology, virology and immunology techniques, including gene cloning, site-directed, deletion and insertion mutagenesis, gene expression, gene arrays, differential gene expression, yeast-two hybrid assays, promoter studies, cell proliferation and apoptosis assays, development of virus vectors and vaccines and T cell assays.

Dr. Laure Aurelian’s research interests include application of antisense chemotherapy to the control of virus infections, immunotherapeutic vaccine. Additional interests are in the molecular and immunological aspects of HSV-associated erythema multiforme.